Trials / Sponsors / Remedy Pharmaceuticals, Inc.
Remedy Pharmaceuticals, Inc.
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion Brain Contusion | Phase 2 | 2019-10-06 |
| Terminated | Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral E Brain Edema, Stroke, Acute | Phase 3 | 2018-08-29 |
| Completed | Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals Ischemic Stroke, Malignant Edema | Phase 2 | 2013-06-13 |
| Completed | Glyburide (RP-1127) for Traumatic Brain Injury (TBI) Traumatic Brain Injury | Phase 2 | 2011-12-17 |
| Completed | Glyburide Advantage in Malignant Edema and Stroke Pilot Ischemic Stroke | Phase 1 / Phase 2 | 2011-05-26 |